ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,596.40
      -1.30%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      83.425
      0.13%
      Bitcoin
      65,433.18
      0.53%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kiniksa Pharmaceuticals International PLC (KNSA)

      7. Kiniksa Pharmaceuticals International PLC (KNSA) Financials

      Kiniksa Pharmaceuticals International PLC

      Kiniksa Pharmaceuticals International PLC (KNSA)

      NASDAQ
      22.35
      0.74
      (3.42%)
      Closed July 16 4:00PM
      Delayed by 15 minutes
      22.35
      0.00
      ( 0.00% )
      Pre Market: 4:05AM
      Delayed by 15 minutes

      Kiniksa Pharmaceuticals International PLC Financial Summary

      The current KNSA market cap is 1.59B. The company's latest EPS is USD 0.1985 and P/E is 112.59.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 48.35M71.47M67.05M83.4M79.86M
      Operating Income -11.2M-3.15M-33.2M81k-16.54M
      Net Income -12.27M14.97M-13.86M25.24M-17.7M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0038.54M220.18M270.26M
      Operating Income -169.96M-157.36M-156.64M9.77M-25.2M
      Net Income -161.87M-161.38M-157.92M183.36M14.08M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 442.86M484.33M483.06M526.32M519.67M
      Total Liabilities 52.77M72.68M77.94M87.48M87.78M
      Total Equity 390.1M411.66M405.13M438.84M431.9M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 254.53M349.46M232.8M459.67M526.32M
      Total Liabilities 29.11M37.53M47.76M63.52M87.48M
      Total Equity 225.42M311.94M185.04M396.15M438.84M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.27M-8.01M8.98M13.3M3.99M
      Investing -37.92M-2.39M-14.66M-29.56M25.52M
      Financing 90k248k800k1.5M3.61M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -158.37M-136.53M-126.3M5.81M13.3M
      Investing 49.21M-23.44M128.64M-8.08M-29.56M
      Financing 84.11M227.09M5.89M2.52M1.5M

      Stats and Ratios

      Market Cap 1.59B
      Price to Earnings Ratio 112.59
      Price to Sales Ratio 5.87
      Price to Cash Ratio 14.69
      Price to Book Ratio 3.61
      Dividend Yield -

      Share Statistics

      Shares Outstanding 70.94M
      Average Volume (1 week) 485.62k
      Average Volume (1 Month) 462.89k
      52 Week Change 52.98%
      52 Week High 22.65
      52 Week Low 14.12
      Spread (Intraday) 3.65 (14.04%)

      Company Info

      Company Name Kiniksa Pharmaceuticals International PLC
      Address third floor
      london W1S 4PZ
      Website https://www.kiniksa.com
      Industry pharmaceutical preparations (2834)